Transfection of the genes for interleukin-12 into the K1735 melanoma and the EMT6 mammary sarcoma murine cell lines reveals distinct mechanisms of antitumor activity
Open Access
- 18 June 2003
- journal article
- Published by Wiley in International Journal of Cancer
- Vol. 106 (5) , 690-698
- https://doi.org/10.1002/ijc.11284
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Interleukin-12 as an Adjuvant for Cancer ImmunotherapyMethods, 1999
- Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGFScience, 1999
- Sustained-Release Interleukin-12 Microspheres in the Treatment of CancerDrug Development and Industrial Pharmacy, 1999
- CELLULAR RESPONSES TO INTERFERON-γAnnual Review of Immunology, 1997
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisPublished by Elsevier ,1996
- Inhibition of Angiogenesis In Vivo by Interleukin 12JNCI Journal of the National Cancer Institute, 1995
- Two different IFN-? nonresponsive variants derived from the B-cell lymphoma 70Z/3Immunogenetics, 1994
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990
- A human beta-actin expression vector system directs high-level accumulation of antisense transcripts.Proceedings of the National Academy of Sciences, 1987
- Transplacental Carcinogenesis by StilbestrolNew England Journal of Medicine, 1971